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Continuing Medical Education
Vestibular Disorders 
Diagnosis, New Classification and Treatment
Michael Strupp, Julia Dlugaiczyk, Birgit Bettina Ertl-Wagner, Dan Rujescu,  
Martin Westhofen, and Marianne Dieterich
Summary
Background: Recent research findings have improved the understanding of the diagnosis, pathophysiology, genetics, 
 etiology, and treatment of peripheral, central, and functional vestibular vertigo syndromes. 
Method: A literature search, with special attention to the current classification, treatment trials, Cochrane analyses, and other 
meta-analyses.
Results: There are internationally accepted diagnostic criteria for benign positional paroxysmal vertigo, Menière’s dis-
ease, bilateral vestibulopathy, vestibular paroxysmia, and functional dizziness. Whether an acute vestibular syndrome is 
central or peripheral can usually be determined rapidly on the basis of the history and the clinical examination. “Cere -
bellar vertigo” is a clinically important entity. For bilateral vestibulopathy, balance training is an effective treatment. For 
 Menière’s disease, preventive treatment with betahistine (48 mg and 144 mg per day) is not superior to placebo. For 
 vestibular paroxysmia, oxcarbazepine has been shown to be effective. Treatments that are probably effective for 
 functional dizziness include vestibular rehabilitation, cognitive behavioral therapy, and serotonin reuptake inhibitors. 
Conclusion: The diagnostic assessment of vestibular syndromes is much easier for clinicians now that it has been inter-
nationally standardized. There is still a lack of randomized, controlled trials on the treatment of, for example, Menière’s 
disease, vestibular migraine, and “cerebellar vertigo.”
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ertigo or dizziness is not a disease in itself, but 
rather a leading symptom of various diseases of dif-
fering etiologies. These include dysfunction of the 
vestibular system, both peripheral (inner ear, vestibular 
nerve) and central (brainstem, cerebellum); functional 
dizziness; and diseases of other causes, including 
blood pressure regulation disorders, such as ortho-
static dizziness, and adverse drug effects. Vertigo is 
often wrongly attributed to an isolated polyneuropathy 
or to poor vision, as these conditions can also cause 
gait instability. Its incidence is approximately 11% per 
year; individuals with have a markedly higher mortal-
ity (adjusted for age, sex, and comorbidities) than 
those without vertigo or dizziness (adjusted odds ratio 
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1.7) (1). The lifetime prevalence of moderate to severe 
vertigo and dizziness is approximately 30% (e1, e2). 
The relative frequency of the individual diseases is 
shown in Figure 1.
Learning objectives
After reading this article, the reader should:
● Have a new attitude to vertigo and dizziness: on 
the basis of the history and physical examination, 
even the non-specialist physician can now, in many 
cases, diagnose vertigo and dizziness rapidly and 
easily and apply effective treatment. 
● Have better knowledge/skills in the following 
areas: internationally accepted diagnostic criteria, 
The diagnostic evaluation of vestibular disorders
This is based on a combination of the clinical history with four 
key questions, physical examination of the vestibular, ocular 
motor, and cerebellar systems, a video head-impulse test, and, 
if the latter is normal, caloric testing. 
Incidence
The incidence of vertigo and dizziness is approximately 11% 
per year.
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physical examination of the vestibular system, and 
treatment options, including physical therapy,
drugs, psychotherapy, and, rarely, surgery. 
Diagnosis and current classification
The diagnostic assessment of the various vestibular 
syndromes is based on the patient’s history and the 
clinical examination of the vestibular, ocular motor, 
and cerebellar systems. When the history is taken, the 
patient should be asked about the nature and temporal 
course of the symptoms. Did they begin suddenly? 
Are they continuous, or do they occur episodically? It 
should be determined which particular disorder is 
present: spinning vertigo, dizziness, postural imbal-
ance, or light-headedness. The modulatory factors are
also important, e.g., changes of body position or the 
activities the patient was engaged in when the symp-
toms arose. One should also ask about any accom-
panying symptoms and their localization. Is the inner 
ear, the brainstem, or the cerebellum affected? Or are 
the attacks typical of migraine? (Box).
In the physical examination, special attention 
should be paid to whether spontaneous or positionally 
induced nystagmus is present. Frenzel’s goggles and 
M glasses have proved to be simple, practical aids to 
nystagmus testing (Figure 2a) (2). The vestibulo-
ocular reflex (VOR) should be evaluated with the
head-impulse test (Figure 2b) and the diagnostic 
 positional maneuvers (Figure 2c, d). Finally, stance 
and gait should be exam ined (Figure 2e, f). Basic, 
 initial screening for hearing impairment can be per-
formed with a tuning fork. 
The two main ancillary laboratory tests for the func-
tion of the VOR are the video head-impulse test (e3) 
(eFigure), which is superior to clinical examination (3),
and caloric testing of the horizontal semicircular canals. 
Finally, diagnostic assessment has been standardized and 
further simplified in the entirely clinically oriented, inter-
nationally accepted diagnostic criteria of the Bárány So-
ciety (free download: www.jvr-web.org/ICVD.html). 
Cochrane analyses and German clinical practice guide-
lines are listed in eTables 1 and 2.
We would like to emphasize that, contrary to wide-
spread belief, the diagnosis of the more common vertigo 
syndromes is actually a simple (though by no means 
trivial) matter. A physician who is not a specialist in this 
area can usually make the right diagnosis. The new diag-
nostic criteria are particularly useful as a practical aid to
the “closely listening and carefully examining clini-
cian”. Consultation of a neurologist, otolaryngologist, or 
specialized center becomes necessary only if specialized 
ancillary testing is required, if the diagnosis is in doubt, 
or if the patient has not responded to a course of appro-
priate treatment.
Diagnosis
The diagnostic assessment has been simplified by the current 
classification of vestibular disorders of the Bárány Society
(www.jvr-web.org/ICVD.html).
Physical examination
In the physical examination, special attention should be paid to 
spontaneous or positionally induced nystagmus. M glasses are 
a simple, practical aid to nystagmus testing.
FIGURE
The frequency of various vestibular syndromes among 34 860 patients in a specialized outpatient clinic
Absolute frequencies of various vertigo/dizziness syndromes in the supraregional specialized outpatient clinic of the German Center for Vertigo 
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Common vestibular syndromes of peripheral 
 origin
Three types of peripheral vestibular disorders with typi-
cal signs and clinical symptoms can be differentiated 
on pathophysiological and functional grounds: 
● Bilateral loss of function (partial or total) of the 
vestibular nerve and/or vestibular end organs: bilateral 
vestibulopathy;
● “Acute unilateral vestibulopathy” manifesting 
itself as an “acute peripheral vestibular syndrome”; 
● Unilateral paroxysmal pathological excitation or, 
more rarely, inhibition of the vestibular nerve and/or 
vestibular end organs (BPPV,  Menière’s disease, vestibu-
lar paroxysmia, third mobile window syndromes) (4).
In the following sections, the current methods of 
diagnostic assessment , pathophysiology, etiology, and 
treatment of the more common peripheral vestibular 
syndromes will be presented in the light of the above 
classification. 
Bilateral vestibulopathy
The diagnostic criteria for bilateral vestibulopathy are 
as follows (5):
● A chronic vestibular syndrome with at least two of 
the following symptoms: instability of stance or 
gait and/or motion-induced blurred vision or oscil-
lopsia while walking or on rapid head movement 
and/or worsening of instability in the dark and/or 
on uneven ground. 
●  No symptoms while sitting or lying under static 
conditions. 
● Bilaterally impaired or absent function of the hori-
zontal vestibulo-ocular reflex (VOR), as docu-
mented by a bilaterally pathological video head-
impulse test (vHIT) for the horizontal semicircular 
canal (VOR gain < 0.6) and/or bilaterally reduced 
caloric excitability (the sum of the peak slow 
phase velocity of the calorically induced nystag-
mus amounts to < 6°/s for each ear). 
●  Symptoms not better explained by another dis-
ease.
 The diagnosis of bilateral vestibulopathy requires 
quantitative testing of vestibular function (5) 
 (eFigure), as the bedside head-impulse test is of low 
sensitivity and specificity (3). In the absence of 
quantitative testing, only “probable bilateral vestibu-
lopathy” can be diagnosed.
The various causes of bilateral vestibulopathy were 
analyzed in a retrospective series of 154 patients (6). 
Twenty different causes were found, identified with 
certainty in 47% of cases and considered only 
BOX
The differential diagnosis of frequent vestibular syndromes 
Temporal course
● Attacks
– seconds to minutes: BPPV (< 1 min*), vestibular paroxysmia (< 1 min*), third 
mobile window syndromes
–  minutes to hours: vestibular migraine (5 min to 72 h*), Menière’s disease 
(20 min to 12 h*), rarely episodic ataxia type 2
● Acute onset, duration of days to a few weeks 
–  acute unilateral vestibulopathy, brainstem or cerebellar stroke
● Persistent symptoms: > 3 months
–  bilateral vestibulopathy, functional dizziness, neurodegenerative  diseases 
(cerebellar vertigo, extrapyramidal disorders) 
Accompanying symptoms
● Hypacusis, tinnitus, pressure sensation in the ear
– Menière’s disease
● Double vision, ataxia, dysarthria, hemiparesis, hemihypesthesia
– central vertigo, e.g., acute central vestibular syndrome or cerebellar vertigo 
● Headache attacks, migraine, photophobia, phonophobia, aura 
– vestibular migraine
● Oscillopsia even at rest
– acute unilateral vestibulopathy, Menière’s disease (during attacks), 
 vestibular migraine, patients with spontaneous nystagmus, e.g., downbeat 
nystagmus 
● Oscillopsia on movement
– bilateral vestibulopathy 
Precipitating and modulating factors
● Symptoms are present even at rest
– attack of Menière’s disease or vestibular migraine, acute unilateral 
 vestibulopathy,  vestibular paroxysmia, acute central vestibular syndrome
● Evoked by changes in body position
– BPPV, central positional vertigo, orthostatic dizziness
● Evoked by changes in pressure or loud noises
– third mobile window syndromes (semicircular canal dehiscence, perilymph 
fistula)
● On standing, walking, and running
– bilateral vestibulopathy (with exacerbation in the dark and no symptoms 
when lying or sitting)
● Certain situations (crowds, wide open spaces) 
– functional dizziness
● Amelioration by distraction, sporting activities, or mild alcohol consumption, 
and generally less severe in the morning 
– functional dizziness
*Current diagnostic criteria: www.jvr-web.org/ICVD.html 
 BPPV, benign paroxysmal positional vertigo
The differential diagnosis of common vestibular 
 disorders
Important clues to the diagnosis are to be sought in the tem-
poral course of the symptoms, any accompanying symptoms, 
and precipitating or modulating factors.
The six most common peripheral vestibular syndromes, in order of 
 decreasing incidence:
Benign paroxysmal positional vertigo, Menière’s disease, acute  unilateral 
 vestibulopathy/vestibular neuritis, bilateral vestibulopathy, vestibular paroyxsmia, 
and the third mobile window syndromes. 
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 pos sible causes in another 22%; in the remaining 
31%, the etiology remained unclear. Ototoxic drugs 
(in particular gentamicin), were most common, fol-
lowed by genetic causes and bilateral Menière’s dis-
ease. Bilateral vestibulopathy can arise at any age. 
The average age at diagnosis lies between 50 and 
60 years (for an overview, see [5]).
The four principles that guide treatment are as 
 follows: 
●  Explaining the cause of the symptoms to the 
 patient.
●  Primary prevention, i.e., avoidance of ototoxic 
substances.
●  Optimal treatment of the underlying disease, e.g., 
Menière’s disease. 
●  Physiotherapy (level I evidence) with daily balance 
training, particularly including head turning in all 
three planes, in order to train the vestibulo-ocular re-
flex (VOR training). Older patients, in particular, 
should additionally undergo training to prevent falls 
under the guidance of a physiotherapist (e4, 7, 8).
Acute unilateral vestibulopathy/vestibular neuritis
Acute unilateral vestibulopathy is characterized by 
spinning vertigo of acute onset that lasts for at least 
24 h (9), accompanied by oscillopsia, a tendency to fall, 
and nausea. Furthermore, horizontal-torsional sponta-
neous nystagmus is seen, with the fast phase beating 
toward the presumably unaffected side; this can be 
suppressed by fixation. The head-impulse test demon-
strates unilateral peripheral vestibular dysfunction of 
the vestibulo-ocular reflex (vHIT gain < 0.7) (eFigure) 
and/or a > 25% difference between the two sides on 
caloric testing. Moreover, the subjective visual verti-
cal is pathologically tilted toward the side of the 
 affected labyrinth.
 No signs of a central ocular motor disturbance or 
acute hearing impairment are found. 
This disease is also referred to as vestibular neu -
ritis, neuronitis, or neuropathy. 
In patients with clinical manifestations of an acute 
vestibular syndrome, the main differential diagnosis 
after acute unilateral vestibulopathy is a lesion of the 
brainstem or cerebellum (usually ischemic). 
The probable, though not yet directly proven, 
 etiology of acute unilateral vestibulopathy is reacti-
vation of a latent herpes simplex virus 1 (HSV-1) in-
fection. This hypothesis is supported, among other 
evidence, by a link to genetic variants of a host factor 
for HSV-1 replication that was revealed by a genome-
wide association study (10).
The efficacy of steroids as an aid to the recovery of 
peripheral vestibular function in acute unilateral 
 vestibulopathy has been shown in a randomized, con-
trolled trial (11) but nonetheless remains controver-
sial; at least one more randomized, controlled trial is 
needed. A prospective observational study indicated 
that the success of steroid treatment depends on the 
latency between symptom onset and the initiation of 
treatment (12). The efficacy of balance training in the 
treatment of acute unilateral vestibulopathy has been 
documented in multiple randomized trials. A particu-
larly important component of balance training is 
 rotation of the head with fixation of a visual target to 
enhance the central vestibular tonus imbalance, which 
is the adequate stimulus for initiating central vestibu-
lar compensation (e4, 8).
Benign paroxysmal positional vertigo
Recurrent attacks of spinning vertigo induced by 
changes in head position relative to the gravitational 
axis, lasting for several seconds each, are the main 
manifestation of benign paroxysmal positional vertigo. 
Nowadays videos of eye movements taken by the pa-
tient himself or herself, with the aid of screening tech-
niques (smart devices [e5]) or with a smartphone (e6) 
can also be helpful to make the diagnosis.
Approximately 95% of all cases of benign paroxys -
mal positional vertigo are idiopathic. A multivariate 
analysis has shown that this condition is significantly 
associated with age, prior falls, and reduced physical 
activity (e7). Individuals with migraine are 2.5 times 
more likely to develop benign peripheral paroxysmal 
positional vertigo than others (e8).
The diagnostic criteria for benign paroxysmal posi-
tional vertigo of the posterior semicircular canal are 
as follows (13): The patient suffers from recurrent 
 attacks of rotational vertigo induced by lying down 
supine or turning into supine position while lying 
down. Each attack lasts less than 1 min. Positional 
nystagmus is present, arising with a short latency after 
the lateral positioning maneuver (the diagnostic 
 Sémont maneuver) (Figure 2) or the Dix–Hallpike 
maneuver. This nystagmus consists of a torsional 
component (the upper pole of the eyes beats toward 
the lower ear) combined with vertical upbeating nys -
tagmus, and it typically lasts less than 1 min. Finally, 
the symptoms cannot be attributed to any other dis-
order. 
The treatment of choice for benign paroxysmal 
positional vertigo of the posterior canal is the Sémont 
or Epley maneuver (level 1 evidence) (14). When 
Acute unilateral vestibulopathy/vestibular neuritis
Acute unilateral vestibulopathy is characterized by spinning 
vertigo that arises acutely and lasts for days to weeks, periph-
eral vestibular horizontal-torsional spontaneous nystagmus, a 
pathological head-impulse test, and the exclusion of an acute 
central vestibular syndrome. 
Treatment recommendation for acute  
unilateral vestibulopathy
The treatment of choice is steroid administration as soon as 
possible after the onset of symptoms, combined with balance 
training to reinforce central compensation. 
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these are correctly performed, the success rate is 
above 95%. Despite the efficacy of these reposition-
ing maneuvers, older patients in particular tend to 
suffer much longer from the consequences of benign 
paroxysmal positional vertigo, with marked resulting 
impairment (e7, e9); follow-up appointments are 
therefore needed. Treating benign paroxysmal posi-
tional vertigo of the posterior canal with sedating anti-
vertiginous drugs is not recommended for any more 
than a short time, and only if the patient suffers from 
marked nausea. There is no need to restrict the pa-
tient’s movements or positions during sleep (14).
Benign paroxysmal positional vertigo of the horizon-
tal semicircular canal is much rarer. It causes linear, hori-
zontal nystagmus (13).
Menière’s disease
The diagnostic criteria for Menière’s disease are as 
 follows (15):
● Two or more spontaneous attacks of vertigo lasting 
20 min to 12 h
● Audiometrically documented hearing loss for fre-
quencies below 2000 Hz bone conduction 
(> 30 dB worse than the other ear in at least two 
neighboring frequencies), associated with vertigo 
attack 
● Fluctuating tinnitus or fullness in the affected ear
● No evidence of another cause.
If low-frequency hearing loss has not been demon-
strated audiometrically, then only the diagnosis of 
probable Menière’s disease can be made according to 
these criteria. It is very helpful that useful portable, 
iPad-based audiometric devices are now available 
with which patients can test their own hearing (e10).
The pathogenesis of Menière’s disease is thought 
to involve a multifactorial disequilibrium of inner-ear 
homeostasis (e11), with endolymphatic hydrops as 
the final common pathway. The latter can be seen on 
delayed contrast-enhanced magnetic resonance im-
aging (MRI) of the inner ear (Figure 3). The speci -
ficity of such findings for  the diagnosis of Menière’s 
disease is a matter of controversy, because imaging 
studies reveal endolymphatic hydrops in the region of 
the saccule in 10% of normal persons and in 40% of 
patients with a sensorineural hearing loss of > 45 dB 
without vestibular symptoms (16). 
Moreover, although nearly all patients with definite 
Menière’s disease have endolymphatic hydrops, the 
latter can also be seen in patients with vertigo syn-
dromes of other etiologies, e.g., vestibular migraine 
(e12).
Figure 2: The clinical examination of a patient complaining of vertigo, dizziness,  
or postural  imbalance. 
a) Inspection for spontaneous nystagmus. This should be performed with and without 
 fixation, with the aid of Frenzel goggles (M glasses, illustrated). 
b) Clinical head-impulse test. The examiner should look for possible refixation saccades, 
which indicate dysfunction of the vestibulo-ocular reflex (VOR). 
c, d) All patients, regardless of their history, should be investigated for positional vertigo with 
rotation of the head by 45° and simultaneous positioning in the opposite direction. 
 Diagnostic positioning maneuvers (SémontPlus) are shown for c) the right posterior 
 semicircular canal and d) the left posterior semicircular canal.
e, f) Romberg test: e) basic test condition with the legs apart and the eyes open; f) advanced 




Benign paroxysmal positional vertigo
Benign paroxysmal positional vertigo can be well treated by 
properly performed positioning maneuvers. Patients should, 
however, always be asked to give feedback concerning the 
outcome of treatment. If symptoms persist, further follow-up is 
indicated. 
Benign paroxysmal positional vertigo of the horizontal semicircular canal
Benign paroxysmal positional vertigo of the horizontal canal is much rarer. It causes 
linear, horizontal nystagmus.
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There is no consensus yet on the preventive treat-
ment of Menière’s disease. The efficacy of individual 
treatments is hard to assess, because of the clinical 
 heterogeneity of the disease, its fluctuating course, and 
its high rate of response to placebo (up to 70% [17]). 
At present, a stepwise concept is recommended, begin-
ning with conservative treatment (e.g., betahistine), 
then non-destructive techniques (e.g., transtympanic 
cortisone application), and, finally, invasive destruc-
tive techniques (e.g., labyrinthectomy). There is no 
evidence to date for the efficacy of a low-salt diet, 
 abstinence from coffee or alcohol, diuretic use, or 
 endolymphatic sac surgery (8–20, e13, e14).
Treatment with betahistine
Betahistine in a dose of 48 or 144 mg/d is not superior 
to placebo, according to a randomized, controlled trial 
on 221 patients in which a strong placebo effect was 
found (17). 
Uncontrolled observational studies have shown 
that higher doses are associated with higher efficacy. 
Individual treatment trials suggest that combining 
 orally administered betahistine with the MAO-B 
 inhibitor selegiline may enhance its efficacy: this can 
be understood in light of the fact that 99% of orally 
ingested betahistine is metabolized in the gastro -
intestinal tract by MAO-B/A. This approach has 
 received support from experimental studies in ani-
mals in a model of acute unilateral vestibulopathy 
(21). On the whole, more randomized and controlled 
trials are needed to study the therapeutic effects of 
 betahistine. 
Administration of gentamicin and steroids 
The transtympanic administration of gentamicin re-
duces the frequency of the vertigo attacks (22). This is 
an ablative treatment that works by vestibulotoxic im-
pairment of vestibular function. In approximately 20% 
of patients, there is ototoxic hearing loss. The utility of 
gentamicin is limited for this reason, and also because 
45% of patients with Menière’s disease develop the 
condition bilaterally.
Transtympanic corticosteroid administration is an 
alternative treatment with demonstrated efficacy in 
double-blind, randomized, controlled trials (22). It is 
neither cochleotoxic nor vestibulotoxic.
Surgery
If conservative treatment, including orally administered 
betahistine and transtympanic corticosteroids, is inef-
fective, surgery may be indicated (e13, e14). Endolym-
phatic sac surgery is recommended by many surgeons, 
but its efficacy has not yet been definitively demon-
strated (20). 
In advanced Menière’s disease, labyrinthectomy 
and simultaneous cochlear implantation leads to the 
cessation of the vertigo attacks and to an improve-
ment of hearing. 
Vestibular paroxysmia
This term, along with its clinical characteristics and 
 pathophysiology, was introduced by Brandt and Dieterich 
in 1994 (23). The current diagnostic criteria for vestibu-
lar paroxysmia are as follows: At least ten attacks of 
spontaneous spinning or non-spinning vertigo; 
 duration less than 1 min; stereotyped phenomenology 
in a particular patient; response to treatment with a 
 sodium-channel blocker; and not better accounted for 
by another diagnosis (24). The presumed cause is con-
tact between a blood vessel and the vestibular nerve in 
the cerebellopontine angle, although imaging studies 
 reveal such a contact in as many as 45% of normal indi-
viduals (e15, e16). For the latter reason, MRI in this con-
dition is indicated mainly to rule out other etiologies. A 
randomized, controlled trial demonstrated the significant 
therapeutic efficacy of oxcarbazepine at a dosage of 
900 mg/day (attack frequency halved), although poor 
 tolerability of the drug led to a 60% dropout rate (25). 
Lac osamide (100–200 mg/day) seems to be a well-
 tolerated alternative, as individual cases of off-label use 
have shown (26).
Third mobile window syndromes (semicircular canal 
dehiscence and, rarely, perilymph fistula)
The main manifestations of third mobile window  syn-
dromes are recurrent attacks of vertigo induced by 
changes in intracranial/middle-ear pressure or loud 
noises, autophony, increased bone conduction, and/or 
pulsatile tinnitus. Dehiscence of the superior semicircu-
lar canal is the most common subtype and is caused by a 
bony defect between the superior semicircular canal and 
the middle cranial fossa (Figure 3), creating a “third 
window” in the inner ear (in addition to the round and 
oval windows) (27). Alongside the clinical history, the 
diagnosis is based on a combination of at least one test 
finding typical of this syndrome, e.g., elevated ampli-
tudes and/or reduced thresholds of cervical/ocular ves-
tibular evoked myogenic potentials (VEMP) (e17), and 
high-resolution computer tomographic imaging of the 
petrous bone (slice thickness ≤ 0.6 mm). It is important 
to note that on CT about 2% of healthy subjects also 
show a thin bone on top of the superior canal. 
Pathogenesis of Menière’s disease
The pathogenesis of Menière’s disease is thought to involve a 
multifactorial disequilibrium of inner-ear homeostasis, of which 
endolymphatic hydrops is the final common pathway.
Betahistine
Betahistine in a dose of 48 or 144 mg/d is not superior to 
placebo, according to a randomized, controlled trial on 221 
 patients in which a strong placebo effect was found.
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For patients with mild symptoms, it usually suffices 
to explain the mechanism of the disease to them and 
for them to avoid marked pressure changes. For pa-
tients who are more severely impaired, surgical treat-
ment is available (27).
Central vestibular syndromes
Central vestibular syndromes (e18) can manifest them-
selves as follows:
● Spinning vertigo and/or instability of stance and/or 
gait, due to ischemic or inflammatory lesions of 
the brainstem or cerebellum 
● Recurrent attacks, as in vestibular migraine or epi-
sodic ataxia type 2 
● A persistent syndrome, as in cerebellar dizziness. 
Acute central vestibular syndrome: ischemia of the 
brainstem or cerebellum
In the acute vestibular syndrome, the most important 
differential diagnosis of an acute peripheral vestibu -
lopathy is a central lesion in the brainstem or cerebel-
lum, usually due to a stroke. The following features 
point to a stroke as the more likely cause: age over 
60 years, a history of arterial hypertension or diabetes 
mellitus, accompanying symptoms referable to the 
central nervous system, and spontaneous and acute 
onset of the symptoms for the first time ever. In the 
clinical examination, the clinician should look for skew 
deviation/vertical divergence of the eyes, in which the 
vertical position of one eye is higher than that of the 
other. Furthermore, the nature of the spontaneous nys -
tagmus is very important: if it cannot be suppressed by 
fixation, it is not a spontaneous nystagmus due to a 
 peripheral vestibular disorder. Important further clues 
indicating a central lesion are a normal head-impulse 
test and a vertical nystagmus as well as a head-shaking 
nystagmus beating in the opposite direction to the spon-
taneous nystagmus.
Acute central vestibular syndrome is an emergency 
calling for immediate referral to a hospital that has the 
relevant diagnostic imaging and, ideally, a stroke unit. 
It should be emphasized here that, in patients with 
acute central vestibular syndrome due to a small 
stroke, MRI, including diffusion-weighted sequences, 
can often be normal in 50% of cases in the first 24 h 
(28). This underlines the importance of the patient’s 
history and clinical examination in determining the 
correct diagnosis. 
Vestibular migraine
Vestibular migraine is the most common cause of recur-
rent, spontaneous attacks of vertigo. Its 1-year preva-
lence is 2.7% among adults in the USA; the average age 
of individuals suffering from vestibular migraine is 
40.9 years, and 64.1% of them are women (29). Ves-
tibular migraine is defined as follows, according to the 
current diagnostic criteria (30):
● The patient has had at least five episodes of ves-
tibular symptoms of moderate or severe intensity 
lasting from 5 min to 72 h.
● The patient has, or has had, migraine with or with-
out aura as defined by the criteria of the Inter-
national Classification of Headache Disorders 
(ICHD).
● At least 50% of the vestibular episodes are pre-
ceded by one or more migraine symptoms: head-
ache with at least two of the following features 
Vestibular paroxysmia
Vestibular paroxysmia consists of recurrent (as many as 100 
times per day), spontaneously arising, brief attacks of vertigo. 
The demonstration of neurovascular conflict by MRI is not spe-
cific to this entity. A convincing response to a sodium-channel 
blocker supports the diagnosis. 
Acute vestibular syndrome
In acute vestibular syndrome, the most important differential 
diagnosis of an acute peripheral vestibulopathy is a central 
lesion in the brainstem or cerebellum, usually due to a stroke. 
Figure 3: Imaging of the inner ear 
a) and b) Contrast-enhanced MRI of a patient with  Menière’s disease: a) evidence of vestibular 
(arrow) and cochlear endolymphatic hydrops in a high-resolution FLAIR sequence 4 h after the 
administration of intravenous contrast medium; b) 3D reconstruction of a segmented, contrast-
enhanced MRI-based visualization of the endo- and perilymphatic spaces (endolymphatic 
 hydrops shown in red and purple). 
c) and d) High-resolution computer-tomographic imaging of the petrous bone, revealing dehis-
cence of the left superior semicircular canal; c) the petrous bone CT depicts the bony defect 
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(unilaterality, pulsatile character, moderate or 
 severe intensity, aggravation by routine physical 
activities), photophobia, phonophobia, visual 
aura.
● The symptoms are not attributable to another ves-
tibular or ICHD diagnosis. 
A single one of the following two criteria suffices 
for the diagnosis of probable vestibular migraine: a 
history of migraine, or migraine symptoms during the 
attack. 
The main differential diagnosis of vestibular mi-
graine is Menière’s disease. Some patients meet the 
diagnostic criteria for both of these disorders; this 
suggests a pathophysiological link between them. 
Vestibular migraine might, for example, lead to a 
disturbance in the inner ear by way of the trigemi-
novascular system, increasing the probability of en-
dolymphatic hydrops  (e19). As there is no evidence 
yet to support any specific treatment for vestibular 
migraine (Cochrane Review [31]), this disorder 
should currently be treated like any other type of mi-
graine. 
Cerebellar dizziness and vertigo
Dizziness, vertigo, and imbalance due to cerebellar dis-
ease present a particular differential-diagnostic chal-
lenge. These patients typically do not present with the 
full spectrum of cerebellar symptoms. The entity of 
“cerebellar dizziness and vertigo” was, therefore, in-
vestigated more precisely in a study encompassing 
369 patients (32), 81% of whom suffered from persis -
tent dizziness, 31% from attacks of vertigo or dizzi-
ness, and 21% from both. Ninety-five percent had 
signs of a central ocular motor disorder (e.g., saccadic 
smooth pursuit, omnidirectional gaze-evoked nystag-
mus, central fixation nystagmus, and, in particular, 
downbeat nystagmus). The diagnosis cerebellar dizzi-
ness/vertigo is clinically relevant because many types 
can be treated with drugs, e.g., episodic ataxia type 2 
(e20) and downbeat nystagmus (e21) with 4-aminopyri-
dine, or certain other types of ataxia with acetyl-DL-
leucine (33, 34).
Functional dizziness
Somatoform/psychogenic vertigo has been internation-
ally designated as functional dizziness since 2017 and 
is probably the single most common type of vertigo 
(Figure); the term covers several subtypes, including 
phobic postural dizziness or persistent postural-per-
ceptual dizziness. The Bárány Society, on the basis of 
many years of experience and in view of the many 
common features of phobic postural vertigo (pho-
bischer Schwankschwindel) (e22) in Germany, chronic 
subjective dizziness in the USA, and visual vertigo in 
the UK (35), has established another entity called “per-
sistent postural-perceptual dizziness” (PPPD) (36). 
This disorder is characterized by persistent dizziness 
and/or unsteadiness on most days over a period of 
3 months or longer, with the symptoms lasting for 
hours per day, but not necessarily the whole day. The 
symptoms arise spontaneously but may be worsened by 
upright posture, active or passive body movements, or 
exposure to moving visual stimuli. Acute or chronic or-
ganic vestibular disorders, neurological or medical ill-
ness, or psychological distress may precede these 
symptoms, appear simultaneously with them, and/or 
outlast them. The symptoms cause marked functional 
impairment. They cannot be better explained by any 
other diagnosis. 
Patients often complain of more or less permanent im-
balance or light-headedness, which is usually less severe 
during sporting activities, on distraction, after the con-
sumption of a small amount of alcohol, or in the morning, 
but is exacerbated by certain situations (e.g., in a crowd 
or in a department store); this can lead to avoidance 
behav ior (“phobic postural dizziness”). Functional diz-
ziness can be pathophysiologically explained as a result 
of heightened self-observation of balance. It typically 
affects individuals with perfectionist personality traits. 
As many as 45% of patients have an organic disease 
before the onset of symptoms: this condition is called 
secondary functional dizziness. 
 A detailed diagnostic evaluation is part of the effec-
tive treatment of this disorder. The work-up frees the 
patient from the fear that the symptoms are due to an 
underlying organic disease. Moreover, the treating 
physician should provide psychoeducation by explain-
ing the mechanism of the disorder to the patient. The 
physician should encourage the patient to participate 
in sporting activities regularly, and a course of ves-
tibular rehabilitation may be advisable (37). Both of 
these measures help the patient regain confidence in his 
or her own ability to maintain balance. If necessary, cog-
nitive behavioral therapy or desensitization by auto-
exposure can be performed. In the event of accompany-
ing anxiety or simultaneous panic attacks, treatment with 
a selective serotonin reuptake inhibitor (38) or other 
antidepressants may be beneficial. 
Approximately 70% of the affected patients can be 
treated successfully in this manner. There have not yet 
been any prospective, controlled trials of the treatment of 
this disorder (39).
Cerebellar dizziness and vertigo
The key to this diagnosis is the examination of eye move-
ments, as practically all patients have at least one oculomotor 
abnormality of cerebellar origin, such as saccadic ocular 
 pursuit, gaze-evoked nystagmus, or downbeat nystagmus. 
Functional dizziness
Functional dizziness is probably the single most common 
 vestibular syndrome. It can usually be diagnosed easily on the 
basis of the current “positive” diagnostic criteria, and its treat-
ment after correct diagnosis is often successful.
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Only one answer is possible per question. Please select the answer that is most appropriate.
Question 1
A 38-year-old school teacher reports that she has had approximately 
10 attacks of spinning vertigo in the past 12 months, usually lasting 
 several hours each. She has also noted hearing loss, tinnitus, and full-
ness in the left ear. Audiological testing reveals a 40-dB low-frequency
 hearing deficit in the left ear. 
What is the probable diagnosis?
a) Recurrent transient ischemic attacks
b) Acute unilateral vestibulopathy
c) Menière’s disease
d) Functional dizziness
e) Superior canal dehiscence syndrome
Question 2
A 44-year-old colleague of yours sustains mild head trauma in a 
 bicycle accident. The next morning, he experiences spinning vertigo 
while turning over in bed; the symptoms subside at rest. He vomits 
 repeatedly. On questioning, he states that the attacks of vertigo are 
triggered by turning over to the left from a supine position and last 
 approximately 30 s each. The clinical examination is normal. A few days 
later, the patient sends you a video showing a nystagmus beating up-
ward and torsionally toward the left ear when he is lying in the left lateral 
decubitus position. The nystagmus lasts approximately 20 s. 
What is the diagnosis? 
a) Post-traumatic loss of labyrinthine function
b) Panic attacks
c) Vertebral artery dissection
d) Orthostatic dizziness
e) Benign paroxysmal positional vertigo
Question 3
Frequent, spontaneously arising vertigo attacks of a few seconds’ 
duration characterize what disorder?
a) Vestibular paroxysmia 
b) Functional dizziness
c) Vestibular migraine
d) Episodic ataxia type 2
e) Bilateral vestibulopathy
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Question 4
A 28-year-old nurse reports that she has suffered from severe, 
persistent spinning vertigo for 2 days, accompanied by appa-
rent movement of her surroundings and a tendency to fall to 
the right. Your examination reveals spontaneous nystagmus 
with the fast phase beating toward the left. The head-impulse 
test is pathological when the head is turned to the right. The 
patient’s hearing and eye movements are normal. 
What is the diagnosis? 
a) Downbeat nystagmus syndrome
b) Acute unilateral vestibulopathy
c) Visual dizziness
d) Semicircular canal dehiscence syndrome
e) Cervicogenic vertigo
Question 5
A 76-year-old man reports that he has been suffering from 
increasing instability of stance and gait for the past 5 years. 
When asked, he further states that he perceives apparent 
motion of the environment while walking. The instability is 
worse in the dark and when he walks on uneven ground. He 
has already fallen three times. On examination, you find a 
bilaterally pathological head-impulse test and a pathological 
Romberg test with the eyes closed. There is no spontane-
ous nystagmus, and the eye movements are normal. 
What is the diagnosis? 
a) Subcortical vascular encephalopathy
b) Recurrent syncope
c) Downbeat nystagmus syndrome
d) Bilateral vestibulopathy
e) Spinal canal stenosis
Question 6
An 18-year-old high-school student states that, for the past 
5 years, she has had attacks of dizziness lasting many min -
utes to many hours, approximately twice per month. The 
 attacks are usually accompanied by a pulsating right-sided 
headache that is exacerbated by physical exertion. She 
 also reports that she suffers from migraine with aura. Your 
examination reveals a mild central ocular motor disorder, 
with mildly saccadic smooth pursuit movements in all gaze 
directions. 
What is the diagnosis?
a) Paroxysmal brainstem attacks
b) Vestibular migraine
c) Upbeat nystagmus syndrome
d) Menière’s disease
e) Third mobile window syndrome
Question 7




d) Unilateral peripheral vestibulopathy
e) Vestibular migraine
Question 8
What is the presumed pathogenesis of Menière’s disease?




e) A lesion in the vestibular cortex
Question 9
A 24-year-old IT specialist reports having suffered from practically con -
tinuous light-headedness of fluctuating intensity over the past 2 years. 
On questioning, he states that the problem is less severe in the morning, 
worsens when he goes to a department store, but improves during sport -
ing activities or after the consumption of a small amount of alcohol. The 
physical examination is unremarkable.
What is the probable diagnosis?
a) Persistent unilateral vestibulopathy
b) Cerebellar dizziness
c) Third mobile window syndrome
d) Incipient Parkinson’s disease
e) Functional dizziness
Question 10




d) The Sémont maneuver
e) Gentamicin 
►Participation is possible only over the Internet: cme.aerzteblatt.de
310 Deutsches Ärzteblatt International | Dtsch Arztebl Int 2020; 117: 300–10
M E D I C I N E
Deutsches Ärzteblatt International | Dtsch Arztebl Int 2020; 117: 300–10 | Supplementary material I
Supplementary material to:
Vestibular Disorders
Diagnosis, New Classification and Treatment
by Michael Strupp, Julia Dlugaiczyk, Birgit Bettina Ertl-Wagner, Dan Rujescu,  
Martin Westhofen, and Marianne Dieterich
Dtsch Arztebl Int 2020; 117: 300–10. DOI: 10.3238/arztebl.2020.0300
e12. Gurkov R, Kantner C, Strupp M, et al.: Endolymphatic hydrops in 
patients with vestibular migraine and auditory symptoms. Eur Arch 
Otorhinolaryngol 2104; 271: 2661–7.
e13. Lim MY, Zhang M, Yuen HW, Leong JL: Current evidence for 
 endolymphatic sac surgery in the treatment of Meniere‘s disease: 
a systematic review. Singapore Med J 2015; 56: 593–8.
e14. Sood AJ, Lambert PR, Nguyen SA, Meyer TA: Endolymphatic sac 
surgery for Meniere‘s disease: a systematic review and meta-
 analysis. Otol Neurotol 2014; 35: 1033–45.
e15. Best C, Gawehn J, Kramer HH, et al.: MRI and neurophysiology 
in vestibular paroxysmia: contradiction and correlation. J Neurol 
Neurosurg Psychiatry 2013; 84: 1349–56.
e16. Sivarasan N, Touska P, Murdin L, Connor S: MRI findings in vestibu-
lar paroxysmia—an observational study. J Vestib Res 2019; 29: 
137–45.
e17. Fife TD, Colebatch JG, Kerber KA, et al.: Practice guideline:  
 cervical and ocular vestibular evoked myogenic potential testing: 
 report of the Guideline Development, Dissemination, and Implemen-
tation Subcommittee of the American Academy of Neurology. 
 Neurology 2017; 89: 2288–96.
e18. Brandt T, Dieterich M: The dizzy patient: don‘t forget disorders of the 
central vestibular system. Nat Rev Neurol 2017; 13: 352–62.
e19. Nakashima T, Pyykko I, Arroll MA, et al. Meniere‘s disease. Nat Rev 
Dis Primers 2016; 2:16028.
e20. Strupp M, Kalla R, Claassen J, et al.: A randomized trial 
of  4-aminopyridine in EA2 and related familial episodic ataxias. 
 Neurology 2011; 77: 269–75.
e21. Claassen J, Spiegel R, Kalla R, et al.: A randomised double-blind, 
cross-over trial of 4-aminopyridine for downbeat nystagmus—effects 
on slowphase eye velocity, postural stability, locomotion and symp-
toms. J Neurol Neurosurg Psychiatry 2013; 84: 1392–9.
e22. Brandt T, Dieterich M. Phobischer Attacken-Schwankschwindel, ein 
neues Syndrom. Münch Med Wochenschr 1986; 128: 247–50.
 eReferences
e1. Neuhauser HK: The epidemiology of dizziness and vertigo.  Handb 
Clin Neurol 2016; 137: 67–82.
e2. Hulse R, Biesdorf A, Hormann K, et al.: Peripheral vestibular dis -
orders: an epidemiologic survey in 70 million individuals. Otol 
 Neurotol 2019; 40: 88–95.
e3. Halmagyi GM, Chen L, MacDougall HG, Weber KP, McGarvie LA, 
Curthoys IS: The video head impulse test. Front Neurol 2017; 8: 
258.
e4. Lehnen N, Kellerer S, Knorr AG, et al.: Head-movement-emphasized 
rehabilitation in bilateral vestibulopathy. Front Neurol 2018; 9: 562.
e5. Feil K, Feuerecker R, Goldschagg N, et al.: Predictive capability of 
an iPad-Based Medical Device (medx) for the diagnosis of vertigo 
and dizziness. Front Neurol 2018, 9: 29.
e6. Shah MU, Lotterman S, Roberts D, Eisen M: Smartphone tele -
medical emergency department consults for screening of nonacute 
dizziness. Laryngoscope 2019; 129: 466–9.
e7. Park MK, Lee DY, Kim YH: Risk factors for positional vertigo and the 
impact of vertigo on daily life: The Korean National Health and 
 Nutrition Examination Survey. J Audiol Otol 2019; 23: 8–14.
e8. Kim SK, Hong SM, Park IS, Choi HG: Association between migraine 
and benign paroxysmal positional vertigo among adults in South 
 Korea. JAMA Otolaryngol Head Neck Surg 2019; 145: 307–12.
e9. Sim E, Tan D, Hill K: Poor treatment outcomes following 
 reposi tioning maneuvers in younger and older adults with benign 
paroxysmal positional vertigo: a systematic review and meta-
 analysis. J Am Med Dir Assoc 2019; 20: 224.
e10. Tse D, Ramsay T, Lelli DA: Novel use of portable audiometry to 
track hearing fluctuations in Meniere‘s disease: a pilot study. Otol 
Neurotol 2019; 40: e130–e4.
e11. Frejo L, Martin-Sanz E, Teggi R, et al.: Extended phenotype 
and  clinical subgroups in unilateral Meniere disease: A cross-
 sectional study with cluster analysis. Clin Otolaryngol 2017; 
42: 1172–80.
M E D I C I N E
II Deutsches Ärzteblatt International | Dtsch Arztebl Int 2020; 117: 300–10 | Supplementary material
History
A 46-year-old engineer reports that he has been suffering from severe, per-
sistent spinning vertigo for the past 24 h. The vertigo arose suddenly; it is 
accompanied by instability of stance and gait, with a tendency to fall to the 
right, and nausea. When he tries to fixate on a target, everything seems to 
move in front of his eyes. On questioning, he states that his hearing is nor-
mal, and he has neither tinnitus nor fullness in the ears. Photophobia and 
phonophobia are likewise absent, and he does not suffer from migraine. He 
has no vascular risk factors. 
Physical examination
On central gaze, there is a low-amplitude spontaneous nystagmus with the 
fast phase beating to the left and a clockwise torsional component (from the 
examiner’s point of view). When the patient wears M glasses, the intensity 
of the spontaneous nystagmus increases markedly. The head-impulse test is 
pathological toward the right. There are no signs of central ocular motor 
disorders: in particular, the alternating cover test reveals no skew deviation, 
nor is there any gaze-evoked nystagmus on rightward gaze, i.e., in the direc-
tion opposite to the rapid phase of the spontaneous nystagmus. The Rinne 
and Weber tuning fork tests are normal. The Romberg test reveals instabil-




The gain of the rightward horizontal vestibulo-ocular reflex (VOR) is 
 reduced to 0.3 (eFigure, below, b); values less than 0.7 indicate a clinically 
relevant unilateral deficit and obviate the need for caloric testing. As 
neither the history nor the physical examination give any reason to suspect 
a central disturbance—in particular, a stroke in the brainstem or cerebel-
lum—no neuroimaging is necessary (and, in any case, the MRI findings are 
often normal in the first 24 h in patients who present with spinning vertigo 
or dizziness as their main symptom of a brainstem stroke).
Diagnosis and differential diagnosis
On the basis of the history and physical findings, an acute unilateral ves -
tibulopathy on the right is diagnosed. 
The three major differential diagnoses are:
●  Acute central vestibular syndrome
●  Menière’s disease (the lack of hearing loss makes this diagnosis less 
likely, although Menière’s disease can begin with only mild symtoms) 
●  Vestibular migraine (not supported by the history).
Treatment
●  To treat nausea and vertigo: dimenhydrinate, 50 mg po tid for 1 day.
● To promote the recovery of peripheral vestibular function: methyl-
prednisolone, initially 100 mg po qd, tapering by −20 mg every 4th 
day to off. 
●  Balance training for at least 15 min three times a day for 4 weeks. 
Course
Four weeks later, the patient reports that his symptoms have markedly im-
proved. He has no spinning vertigo any more, and physical examination no 
longer reveals spontaneous nystagmus. The rightward VOR gain is now 
0.7, and there is still a mild tendency to fall to the right on the Romberg test 
with the eyes closed. 
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eFigure: Video head-impulse test (vHIT): 
Left: Quantitative investigation of the function of the horizontal vestibulo-ocular reflex 
(hVOR). The angular velocities of eye and head movements are measured simulta-
neously, and their quotient — called “gain” — is calculated. 
Below: Original recordings, with values on head turning to the right (marked in red) 
and to the left (marked in blue). 
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Normal findings:  
 
The angular velocities of eye movement 
(black curve) and head movement (gray 
curve) are nearly identical: gain approxi-
mately 1. 
A patient with right unilateral vestibu -
lopathy 
 
The right-sided h-VOR gain is reduced to 
0.3 (black arrow), and there are both 
covert and overt correcting saccades 
(white arrows). 
A patient with bilateral vestibulopathy 
(BVP) 
 
Reduced VOR gain bilaterally: 
0.05 (black arrow), with both covert and 
overt correcting saccades  (white arrows)
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eTABLE 1
AWMF guidelines on vertigo (www.awmf.org, as of 30 March 2020)
Title








Until 29 November 2020
Forthcoming;
as of 29 April 2019: guideline documents sub-
mitted, review not yet completed, completion 
expected by 31 December 2020
Issuing society
German Society for General Practice and Family 
Medicine (Deutsche Gesellschaft für Allgemein-
medizin) und Familienmedizin, DEGAM)
German Society for Neurology (Deutsche 
 Gesellschaft für Neurologie) and German 
 Society for Otorhinolaryngology and Head and 
Neck Surgery (Deutsche Gesellschaft für 
Hals-Nasen- Ohren-Heilkunde, Kopf- und 
eTABLE 2
Cochrane reviews on vertigo (www.cochranelibrary.com, as of 30 March 2020)
Diagnosis
Acute unilateral vestibulopathy
Unilateral peripheral vestibular 
 dysfunction





Corticosteroids for the treatment of idiopathic acute vestibular dysfunction 
(vestibular neuritis)
Vestibular rehabilitation for unilateral peripheral vestibular dysfunction
The Epley (canalith repositioning) manoeuvre for treatment of benign  
paroxysmal positional vertigo
Modifications of the Epley (canalith repositioning) manoeuvre for posterior  
canal benign paroxysmal positional vertigo (BPPV)
Betahistine for Menière’s disease or syndrome
Diuretics for Menière’s disease or syndrome
Intratympanic gentamicin for Menière’s disease or syndrome
Intratympanic steroids for Menière’s disease or syndrome
Surgery for Menière’s disease
Positive pressure therapy for Menière’s disease or syndrome
Restriction of salt, caffeine and alcohol intake for the treatment of  Menière’s 
disease or syndrome
Pharmacological agents for the prevention of vestibular migraine
Betahistine for symptoms of vertigo
Date of publication 
11  May  2011
13  January  2015
8  December  2014
18  April  2012
22  January  2001; update 2008, 2011
19  July  2006; update 2010
16  March  2011
6  July  2011
28  February  2013
10 March  2015
31  December  2018
21 June  2015; update 2018 
21 June  2016
